Other Species / Isoforms
  NDR1 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T4
____MAMTGSTPCSS
0 1
NDR1 (human) ____MAMtGstPCss T4-p
NDR1 (mouse) ____MAMTGSTPCSS T4
S6
__MAMTGSTPCSSMS
1 0
NDR1 (human) __MAMtGstPCssMs S6-p
NDR1 (mouse) __MAMTGSTPCSSMS S6
T7
_MAMTGSTPCSSMSN
2 1
NDR1 (human) _MAMtGstPCssMsN T7-p
NDR1 (mouse) _MAMTGSTPCSSMSN T7
S10
MTGSTPCSSMSNHTK
1 0
NDR1 (human) MtGstPCssMsNHtk S10-p
NDR1 (mouse) MTGSTPCSSMSNHTK S10
S11
TGSTPCSSMSNHTKE
1 0
NDR1 (human) tGstPCssMsNHtkE S11-p
NDR1 (mouse) TGSTPCSSMSNHTKE S11
S13
STPCSSMSNHTKERV
0 1
NDR1 (human) stPCssMsNHtkERV S13-p
NDR1 (mouse) STPCSSMSNHTKERV S13
T16
CSSMSNHTKERVTMT
0 1
NDR1 (human) CssMsNHtkERVTMT T16-p
NDR1 (mouse) CSSMSNHTKERVTMT T16
K17
SSMSNHTKERVTMTK
0 1
NDR1 (human) ssMsNHtkERVTMTK K17-ub
NDR1 (mouse) SSMSNHTKERVTMTK K17
T26
RVTMTKVTLENFYSN
0 1
NDR1 (human) RVTMTKVtLENFySN T26-p
NDR1 (mouse) RVTMTKVTLENFYSN T26
Y31
KVTLENFYSNLIAQH
1 8
NDR1 (human) KVtLENFySNLIAQH Y31-p
NDR1 (mouse) KVTLENFYSNLIAQH Y31
K58
VMEEEGLKDEEKRLR
0 1
NDR1 (human) VMEEEGLkDEEkRLR K58-ac
NDR1 (mouse) VMEEEGLKDEEKRLR K58
K62
EGLKDEEKRLRRSAH
0 1
NDR1 (human) EGLkDEEkRLRRSAH K62-ub
NDR1 (mouse) EGLKDEEKRLRRSAH K62
T74
SAHARKETEFLRLKR
2 0
NDR1 (human) SAHARKEtEFLRLKR T74-p
NDR1 (mouse) SAHARKETEFLRLKR T74
K93
LEDFESLKVIGRGAF
0 1
NDR1 (human) LEDFESLkVIGRGAF K93-ub
NDR1 (mouse) LEDFESLKVIGRGAF K93
K118
TGHVYAMKILRKADM
0 1
NDR1 (human) TGHVYAMkILRKADM K118-ub
NDR1 (mouse) TGHVYAMKILRKADM K118
T183
TLLMKKDTLTEEETQ
1 0
NDR1 (human) TLLMKKDtLTEEETQ T183-p
NDR1 (mouse) TLLMKKDTLTEEETQ T183
K223-ac
DNLLLDSkGHVKLSD
0 1
NDR1 (human) DNLLLDSKGHVKLSD K223
NDR1 (mouse) DNLLLDSkGHVKLSD K223-ac
S264-p
FTFQNMNsKRKAEtW
Upstream
0 12
Treatment
  • insulin
  • LY294002
  • MK-2206
NDR1 (human) FTFQNMNsKRKAEtW S264-p
NDR1 (mouse) FTFQNMNsKRKAEtW S264-p
T270-p
NsKRKAEtWKRNRRQ
0 2
NDR1 (human) NsKRKAEtWKRNRRQ T270-p
NDR1 (mouse) NsKRKAEtWKRNRRQ T270-p
S281-p
NRRQLAFsTVGTPDy
Upstream
5 15
Treatment
  • okadaic_acid
NDR1 (human) NRRQLAFstVGtPDy S281-p
NDR1 (mouse) NRRQLAFsTVGTPDy S281-p
T282
RRQLAFsTVGTPDyI
0 12
NDR1 (human) RRQLAFstVGtPDyI T282-p
NDR1 (mouse) RRQLAFsTVGTPDyI T282
T285
LAFsTVGTPDyIAPE
0 5
NDR1 (human) LAFstVGtPDyIAPE T285-p
NDR1 (mouse) LAFsTVGTPDyIAPE T285
Y288-p
sTVGTPDyIAPEVFM
0 5
NDR1 (human) stVGtPDyIAPEVFM Y288-p
NDR1 (mouse) sTVGTPDyIAPEVFM Y288-p
K377
APGVEEIKNNLFFEG
0 1
NDR1 (human) APGVEEIkSNSFFEG K377-ub
NDR1 (mouse) APGVEEIKNNLFFEG K377
T407
EIKSIDDTSNFDEFP
1 0
NDR1 (human) EIKSIDDtSNFDEFP T407-p
NDR1 (mouse) EIKSIDDTSNFDEFP T407
Y443-p
KDWVFINytYKRFEG
0 2
NDR1 (human) KDWVFINytyKRFEG Y443-p
NDR1 (mouse) KDWVFINytYKRFEG Y443-p
T444-p
DWVFINytYKRFEGL
Upstream
6 3
Treatment
  • okadaic_acid
NDR1 (human) DWVFINytyKRFEGL T444-p
NDR1 (mouse) DWVFINytYKRFEGL T444-p
Y445
WVFINytYKRFEGLt
0 3
NDR1 (human) WVFINytyKRFEGLt Y445-p
NDR1 (mouse) WVFINytYKRFEGLt Y445
T452-p
YKRFEGLtARGAIPS
0 12
NDR1 (human) yKRFEGLtArGAIPS T452-p
NDR1 (mouse) YKRFEGLtARGAIPS T452-p
R454
RFEGLtARGAIPSYM
0 1
NDR1 (human) RFEGLtArGAIPSyM R454-m1
NDR1 (mouse) RFEGLtARGAIPSYM R454
Y460
ARGAIPSYMKAAK__
0 1
NDR1 (human) ArGAIPSyMKAAK__ Y460-p
NDR1 (mouse) ARGAIPSYMKAAK__ Y460